Article
Metabolomics and Proteomics in Type 2 Diabetes
21 May 2020
Abstract excerpt
The persistent increase in the worldwide burden of type 2 diabetes mellitus (T2D) and the accompanying rise of its complications, including cardiovascular disease, necessitates our understanding of the metabolic disturbances that cause diabetes mellitus. Metabolomics and proteomics, facilitated by recent advances in high-throughput technologies, have given us unprecedented insight into circulating biomarkers of...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
